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In 1937, after qualifying as a medical doctor and before
taking up his appointment as a fellow at Magdalen Col-
lege, Oxford, Hugh Sinclair visited Herbert Evans, the co-
discoverer with Katherine Scott Bishop of vitamin E, and
became interested in the possibility that some fatty acid
deficiencies might account for the rise in ischaemic heart
disease in the Western world [1,2]. In his research letter
entitled 'Deficiency of essential fatty acids and atheroscle-
rosis, etcetera' published in the Lancet in 1956 [3], Sinclair
provided evidence that cardiovascular disease and, in par-
ticular, atherosclerosis, might be associated with a defi-
ciency of what we now call long-chain polyunsaturated
fatty acids; he suggested that the etcetera pointed to the
likelihood that diseases other than cardiovascular disease
might be related to a deficiency in fatty acids [2,3]. One of
his students at Oxford, David Horrobin, was instrumental
in establishing a theoretical framework demonstrating
that this might be true of neuropsychiatric disorders [4].
In turn, it was my very great privilege and honour to col-
laborate with, and be taught by, the late David Horrobin
while establishing that fatty acid interventions might
indeed have a therapeutic part to play in neuropsychiatric
disorders ranging from depression to Huntington's dis-
ease (chorea) [5,6].
In December 2007 the Organizing and Scientific Commit-
tee of the 3rd International Congress on Brain & Behaviour
invited me to chair a session on the theme of fatty acids
and neuropsychiatric disorders. This supplement is based
on the proceedings of that meeting and includes papers
co-authored by Dr. Marcelo Bustos, Professor Graeme
Bydder, Professor Massimo Cocchi, Dr. Serena Counsell,
Dr. Gavin Hamilton, Professor Brian Ross, Dr. Nadeem
Saeed, Dr. Lucio Tonello, Dr. Ian Treasaden, Dr. Sofia
Tsaluchidu and me. In the first paper [7], evidence is pro-
vided from the in vivo 31-phosphorus neurospectroscopy
phosphodiester peak which indexes the phosphorylated
polar head groups glycerophosphorylcholine and glycero-
phosphorylethanolamine that exhaled ethane is a
biomarker of cerebral n-3 polyunsaturated fatty acid per-
oxidation in humans, a finding which clearly may have
implications for the use of this non-invasive biomarker in
future research. The second paper [8], entitled 'The use of
artificial neural networks to study fatty acids in neuropsy-
chiatric disorders' demonstrates for the first time that the
self-organizing map, an unsupervised competitive-learn-
ing network algorithm which forms a nonlinear projec-
tion of a high-dimensional data manifold on a regular,
low-dimensional grid, is an optimal type of artificial neu-
ral network to use for the task of analyzing platelet fatty
acids in neuropsychiatric disorders. Cigarette smoking
appears to be relatively common in sufferers of certain
neuropsychiatric disorders, such as schizophrenia. It is
important, therefore, to ascertain the extent to which
smoking is a confounder when studying oxidative stress in
such disorders. This is the subject of the third paper [9], 'A
comparison of oxidative stress in smokers and non-smok-
ers: an in vivo human quantitative study of n-3 lipid per-
oxidation', which has a surprising result. The fourth paper
[10], 'Fatty acids and oxidative stress in psychiatric disor-
ders', is a systematic review of published evidence for
increased oxidative stress in such disorders. The fifth
paper [11] presents the first voxel-based morphometry
study of grey matter changes in the whole brain in schizo-
phrenia associated with a history of seriously and vio-
lently offending. Finally, the last paper [12] describes
cerebral spectroscopic and oxidative stress studies in
patients with schizophrenia who have dangerously vio-
lently offended.
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I should like to express my thanks to the organizers of the
conference and to the editor and staff of BMC Psychiatry,
with particular thanks to Ros Dignon of BioMed Central,
who has been of immense help in putting this supple-
ment together.
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